本文已被:浏览 187次 下载 240次
Received:April 13, 2026 Published Online:October 23, 2026
Received:April 13, 2026 Published Online:October 23, 2026
中文摘要: 目的 探讨基质金属蛋白酶-12(MMP-12)在胃癌组织肿瘤相关巨噬细胞(TAMs)中的表达特征,分析其与临床病理参数、幽门螺杆菌(Hp)感染及患者预后的关系。方法 回顾性收集2021 年1 月至2024 年12 月经病理学确诊的100 例胃癌患者的手术切除样本。采用多重荧光免疫组化检测胃癌及对应癌旁正常组织中CD163+ TAMs 及MMP-12 的表达,并行定量分析。根据MMP-12+ TAMs 比例的中位值将患者分为高表达组与低表达组各50 例,比较两组间临床病理特征的差异,分析其与Hp 感染的相关性。术后随访截止2025 年12 月,终点事件为全因死亡。用Kaplan-Meier 法及log-rank 检验评估MMP-12 表达与患者总生存期的关系,用Cox 比例风险回归模型分析其独立预后价值。结果 胃癌组织中MMP-12+ TAMs 比例(24.56±5.00)%显著高于癌旁组织(17.21±4.50)%(t=12.840,P<0.01)。MMP-12 高表达与肿瘤浸润深度更深、TNM 分期更晚及淋巴结转移率更高显著相关(P<0.01)。Hp 感染组MMP-12+ TAMs 比例(26.70±5.21)%明显高于非感染组(23.30±4.45)%(t=3.461,P<0.01)。生存分析显示,MMP-12 低表达组患者总生存期显著优于高表达组(P<0.01)。多因素Cox回归分析显示,MMP-12 高表达是胃癌患者全因死亡的独立影响因素(HR=1.416,95%CI:1.180~1.699,P<0.01)。结论 MMP-12 在胃癌TAMs 中高表达,与肿瘤恶性进展、Hp 感染及不良预后密切相关,或可作为评估胃癌患者预后的潜在生物标志物。
Abstract:Objective To investigate the expression characteristics of matrix metalloproteinase-12(MMP-12)in tumor-associated macrophages(TAMs)in gastric cancer(GC)tissues and analyze its associations with clinicopathological parameters,Helicobacter pylori(Hp)infection,and prognosis of the patients. Methods Surgical resection samples from 100 GC patients diagnosed pathologically from January 2021 to December 2024 were retrospectively collected. The expression of CD163+ TAMs and MMP-12 in GC tissues and corresponding adjacent normal tissues was detected using multiplex fluorescence immunohistochemistry and quantitatively analyzed. Patients were divided into high-and low-expression groups based on the median proportion of MMP-12+ TAMs,with 50 cases each. Differences in clinicopathological features between the two groups were compared,and the correlation with Hp infection was analyzed. Postoperative follow-up was conducted up to December 2025,and the endpoint event was all-cause mortality. Kaplan-Meier method and log-rank test were used to assess the association between MMP-12 expression and overall survival. Cox proportional hazards regression model was applied to analyze its independent prognostic value. Results The proportion of MMP-12+ TAMs was significantly higher in GC tissues(24.56±5.00)% than that in adjacent normal tissues(17.21±4.50)%(t=12.840,P<0.01). High MMP-12 expression was significantly associated with deeper tumor invasion,higher TNM stage,and a higher rate of lymph node metastasis(P<0.01). The proportion of MMP-12+ TAMs in the Hp infected group(26.70±5.21)% was significantly higher than that in the non-infected group(23.30 ± 4.45)%(t=3.461,P<0.01). Survival analysis showed that patients in the MMP-12 low-expression group had significantly better overall survival compared to the high-expression group(P<0.01). Multivariate Cox regression analysis confirmed that high MMP- 12 expression was an independent influencing factor for all-cause mortality in GC patients(HR=1.416,95%CI:1.180-1.699,P<0.01).Conclusion MMP-12 is highly expressed in TAMs of GC tissues and is closely associated with tumor progression,Hp infection,and poor prognosis,suggesting its potential as a prognostic biomarker in GC.
keywords: Gastric cancer Tumor-associated macrophages Matrix metalloproteinase- 12 Helicobacter pylori Tumor progression Poor prognosis
文章编号: 中图分类号:R735.2 文献标志码:A
基金项目:湖南省自然科学基金(2025JJ50598)
引用文本:
